Brilliant green 0.1% topical solution United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

brilliant green 0.1% topical solution

special order - brilliant green - cutaneous paint - 1mg/1ml

Brilliant green 0.5% topical solution United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

brilliant green 0.5% topical solution

special order - brilliant green - cutaneous paint - 5mg/1ml

Brilliant green Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

brilliant green

esco-pharm llc - brilliant green - solution for external use - 10mg/ml

Brilliant green solution for external use Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

brilliant green solution for external use

esco-pharm llc - brilliant green - solution for external use - 10mg/ml

Brilliant Rejuv 20 mg (2%w/v)/250 mcg (0.025%w/v) Topical Solution Philippines - English - FDA (Food And Drug Administration)

brilliant rejuv 20 mg (2%w/v)/250 mcg (0.025%w/v) topical solution

brilliant skin essentials inc. - hydroquinone , tretinoin - topical solution - 20 mg (2%w/v)/250 mcg (0.025%w/v)

Brilliant Rejuv 20mg (2%w/w)/500mcg (0.05%w/w) per gram Topical Cream Philippines - English - FDA (Food And Drug Administration)

brilliant rejuv 20mg (2%w/w)/500mcg (0.05%w/w) per gram topical cream

brilliant skin essentials inc. - hydroquinone , tretinoin - topical cream - 20mg (2%w/w)/500mcg (0.05%w/w) per gram

TISSUEBLUE- brilliant blue g injection, solution United States - English - NLM (National Library of Medicine)

tissueblue- brilliant blue g injection, solution

d.o.r.c. dutch ophthalmic research center (international) b.v. - brilliant blue g (unii: m1zrx790si) (brilliant blue g - unii:m1zrx790si) - tissueblue (brilliant blue g ophthalmic solution) 0.025% is is a disclosing agent indicated to selectively stain the internal limiting membrane (ilm). none risk summary there are no available data on the use of tissueblue 0.025% in pregnant women to inform a drug associated risk. systemic absorption of tissueblue 0.025% in humans is expected to be negligible following intravitreal injection and subsequent removal of the drug at the completion of surgical procedures. due to the negligible systemic exposure, it is not expected that maternal use of tissueblue 0.025% will result in fetal exposure to the drug. adequate animal reproduction studies were not conducted with tissueblue 0.025%. risk summary no data are available regarding the presence of brilliant blue g in human milk after intraocular administration of tissueblue 0.025%, or the effects on the breastfed infant or the effects on milk production. however, breastfeeding is not expected to result in exposure of the child to b

Brilliant-C Pluz Capsule Philippines - English - FDA (Food And Drug Administration)

brilliant-c pluz capsule

n/a; distributor: brilliant skin essentials inc - sodium ascorbate , zinc sulfate monohydrate - capsule - 562.5mg (equivalent to 500mg ascorbic acid)/27.5mg (equivalent to 10mg elemental zinc)

AQUA CURE BRILLIANT CHLORINE TABLETS MULTI FUNCTION STABILIZED POOL SANITIZER Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

aqua cure brilliant chlorine tablets multi function stabilized pool sanitizer

klorman industries pty ltd - chlorine present as trichloroisocyanuric acid; copper present as copper sulfate pentahydrate - tablet (inc. pellet, bolus, suppository, capsule) - chlorine present as trichloroisocyanuric acid mineral-chlorine-acid active 810.0 g/kg; copper present as copper sulfate pentahydrate mineral-copper active 7.5 g/kg - pool chlorine - swimming pool - outdoor - algae | bacteria | clarifier | lowers ph | reduces loss of chlorine to sunlight | water treatment/sanitiser | pool clarifier | spa clarifier

neodisher brilliant tabs United Kingdom - English - DrWeigert

neodisher brilliant tabs

dr. weigert -